Diana M. Toivola

Protein phosphatases maintain the organization and structural interactions of hepatic keratin intermediate filaments.

J. Eriksson, R. Goldman, D. Toivola, 1997, Journal of cell science.

Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems

Ion Petre, Maren Preis, Niklas Sandler, 2017, Advanced healthcare materials.

Choosing analytical strategy for microcystins

J. Eriksson, J. Meriluoto, D. Toivola, 1996 .

Toxins affecting cell signalling and alteration of cytoskeletal structure.

J. Eriksson, D. Toivola, Diana M. Toivola, 1999, Toxicology in vitro : an international journal published in association with BIBRA.

Identification of protein phosphatase 2A as the primary target for microcystin‐LR in rat liver homogenates

J. Eriksson, D. Brautigan, D. Toivola, 1994, FEBS letters.

Adrenoceptor activity of muscarinic toxins identified from mamba venoms

J. Meriluoto, J. Kukkonen, D. Toivola, 2011, British journal of pharmacology.

Sphingosine kinase 1 overexpression induces MFN2 fragmentation and alters mitochondrial matrix Ca2+ handling in HeLa cells.

E. Dufour, J. Parys, D. Toivola, 2019, Biochimica et biophysica acta. Molecular cell research.

Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer.

Cecilia Sahlgren, Jessica M Rosenholm, J. Rosenholm, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Design considerations for mesoporous silica nanoparticulate systems in facilitating biomedical applications

N. Prabhakar, D. Karaman, J. Rosenholm, 2014 .